EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
1. EHang shares fell 8.5% after FY2025 sales guidance cut. 2. Sales outlook reduced from $123.3 million to $69.8 million. 3. U.S. stock futures were down, impacting investor sentiment. 4. Competitors also faced declines in pre-market trading. 5. EHang’s poor performance reflects broader market challenges.